𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Abciximab administration and clinical outcomes after percutaneous intervention for in-stent restenosis

✍ Scribed by Ali Moustapha; Abid R. Assali; Stefano Sdringola; S. Wamique Yusuf; William K. Vaughn; R. David Fish; George W. Schroth; Zvonimir Krajcer; Oscar R. Rosales; Richard W. Smalling; H. Vernon Anderson


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
48 KB
Volume
56
Category
Article
ISSN
1522-1946

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Impact of restenosis and disease progres
✍ Mohamed Loutfi; Niall T. Mulvihill; Marco Boccalatte; Bruno Farah; Jean Fajadet; πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 49 KB πŸ‘ 1 views

## Abstract Clinical outcome after percutaneous coronary intervention (PCI) is significantly worse in diabetic patients in comparison to nondiabetic patients. The subset of diabetic patients in the ARTS trial treated with multivessel stenting had the lowest 1‐year event‐free survival. We examined o

Clinical and angiographic follow-up afte
✍ Shpend Elezi; Adnan Kastrati; Martin Hadamitzky; Josef Dirschinger; Franz-Josef πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 75 KB πŸ‘ 2 views

The objective of this study was to assess the angiographic and clinical outcome of patients with coronary in-stent restenosis treated with balloon angioplasty with provisional stenting. The study included 375 consecutive patients with in-stent restenosis managed with balloon angioplasty alone or com